Best-selling in Textbooks
Save on Textbooks
- AU $56.99Trending at AU $71.18
- AU $13.90Trending at AU $17.77
- AU $29.08Trending at AU $33.18
- AU $30.74Trending at AU $37.24
- AU $23.32Trending at AU $32.85
- AU $71.09Trending at AU $79.99
- AU $50.05Trending at AU $66.59
About this product
- DescriptionThe difficulties associated with making risk assessments on the basis of experimental results are familiar to practitioners in many fields- engineering, epidemiology, chemistry, etc. These difficulties are particularly common in problems that have dynamic and stochastic characteristics driven by multiple purposes and goals, with complex interconnections and inter- dependencies. Acquiring an appropriate data base, processing and analyzing model results, and transmitting these results at an appropriate technical, social, political, and institutional level are additional difficulties that must be addressed. This book is grounded on the premise that risks are best assessed on the basis of experimental results and sound mathematical analyses, coupled with the kwledge of experts. The carcigenicity prediction and battery selection (ePBS) approach described herein provides a systematic mechan- ism-a synthesis of systems and statistical and decision analyses-to aid researchers and decision makers in the critical field of carcigenicity prediction in selecting an appropriate battery of tests to use and in translating experimental results into information that can be used as an aid to decision making.
- Author(s)F. K. Ennever,Herbert S. Rosenkranz,J. PetEdwards,Vira Chankong,Y. Y. Haimes
- PublisherSpringer-Verlag New York Inc.
- Date of Publication29/03/2012
- SubjectClinical Medicine: Professional
- Place of PublicationNew York
- Country of PublicationUnited States
- ImprintSpringer-Verlag New York Inc.
- Content Notebiography
- Weight334 g
- Width152 mm
- Height229 mm
- Spine12 mm
- Format DetailsTrade paperback (US)
- Edition StatementSoftcover reprint of the original 1st ed. 1989
This item doesn't belong on this page.
Thanks, we'll look into this.